PRME
Prime Medicine, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.70
−0.27%Leverage
- Debt / equity
- 2.83x
- Net debt / equity
- 1.63x
- Debt / assets
- 0.45x
- Debt / EBITDA
- -0.62x
- Net debt / EBITDA
- -0.36x
Liquidity & coverage
- Current ratio
- 3.05x
- Quick ratio
- 3.05x
- Cash ratio
- 3.00x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $65.1M
Cash & dividend
- FCF / debt
- -1.39x
- Cash flow / debt
- -1.39x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- -44.1%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026